Literature DB >> 3191773

Miliary tuberculosis due to intravesical bacillus Calmette-Guerin therapy.

R C Gupta1, R Lavengood, J P Smith.   

Abstract

While receiving treatment for bladder carcinoma with intravesical BCG, a 78-year-old man developed a clinical illness and roentgenographic manifestation of miliary tuberculosis. The transbronchial lung biopsy demonstrated granulomas with giant cells. Treatment with antituberculosis therapy resulted in complete resolution of the illness. The pathogenesis of this complication was considered to be due to pulmonary infection by BCG from the bladder source and differs from previously reported cases of interstitial pulmonary infiltrates which more likely represent a hypersensitivity reaction to BCG.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3191773     DOI: 10.1378/chest.94.6.1296

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  8 in total

1.  A case of BCG sepsis with bone marrow and liver involvement after intravesical BCG instillation.

Authors:  B Dederke; E O Riecken; T Weinke
Journal:  Infection       Date:  1998 Jan-Feb       Impact factor: 3.553

2.  Pulmonary tuberculosis due to bacille Calmette-Guérin.

Authors:  D Kirsten; U Rieger; K H Schröder; A Böhle; H Magnussen
Journal:  Clin Investig       Date:  1993-10

3.  Subclinical miliary Mycobacterium bovis following BCG immunotherapy for transitional cell carcinoma of the bladder.

Authors:  Chang-Ho Ryan Choi; Sang Oh Lee; Geoff Smith
Journal:  BMJ Case Rep       Date:  2014-05-08

4.  [Sepsis and multiple organ failure after BCG-instillation for bladder cancer].

Authors:  A Elmer; U Bermes; L Drath; E Büscher; A Viertel
Journal:  Internist (Berl)       Date:  2004-08       Impact factor: 0.743

5.  Complications of intravesical bacillus calmette-guérin.

Authors:  Liam C Macleod; Tin C Ngo; Mark L Gonzalgo
Journal:  Can Urol Assoc J       Date:  2014-07       Impact factor: 1.862

Review 6.  Bacillus Calmette-Guérin (BCG) infection following intravesical BCG administration as adjunctive therapy for bladder cancer: incidence, risk factors, and outcome in a single-institution series and review of the literature.

Authors:  María Asunción Pérez-Jacoiste Asín; Mario Fernández-Ruiz; Francisco López-Medrano; Carlos Lumbreras; Ángel Tejido; Rafael San Juan; Ana Arrebola-Pajares; Manuel Lizasoain; Santiago Prieto; José María Aguado
Journal:  Medicine (Baltimore)       Date:  2014-10       Impact factor: 1.889

Review 7.  Bacille Calmette-Guérin (BCG) spondylitis with adjacent mycotic aortic aneurysm after intravesical BCG therapy: a case report and literature review.

Authors:  Takuya Kusakabe; Kenji Endo; Itaru Nakamura; Hidekazu Suzuki; Hirosuke Nishimura; Shinji Fukushima; Kengo Yamamoto
Journal:  BMC Infect Dis       Date:  2018-06-28       Impact factor: 3.090

8.  A 56-Year-Old Male With Weight Loss, Night Sweats, Dyspnea, and Bladder Cancer.

Authors:  Bradley C Sanville; Brooks T Kuhn
Journal:  J Investig Med High Impact Case Rep       Date:  2021 Jan-Dec
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.